» Articles » PMID: 32508596

Methylene Blue Preserves Cytochrome Oxidase Activity and Prevents Neurodegeneration and Memory Impairment in Rats With Chronic Cerebral Hypoperfusion

Overview
Specialty Cell Biology
Date 2020 Jun 9
PMID 32508596
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic cerebral hypoperfusion in neurocognitive disorders diminishes cytochrome oxidase activity leading to neurodegenerative effects and impairment of learning and memory. Methylene blue at low doses stimulates cytochrome oxidase activity and may thus counteract the adverse effects of cerebral hypoperfusion. However, the effects of methylene blue on cytochrome oxidase activity during chronic cerebral hypoperfusion have not been described before. To test this hypothesis, rats underwent bilateral carotid artery occlusion or sham surgery, received daily 4 mg/kg methylene blue or saline injections, and learned a visual water task. Brain mapping of cytochrome oxidase activity was done by quantitative enzyme histochemistry. Permanent carotid occlusion for 1 month resulted in decreased cytochrome oxidase activity in visual cortex, prefrontal cortex, perirhinal cortex, hippocampus and amygdala, and weaker interregional correlation of cytochrome oxidase activity between these regions. Methylene blue preserved cytochrome oxidase activity in regions affected by carotid occlusion and strengthened their interregional correlations of cytochrome oxidase activity, which prevented neurodegenerative effects and facilitated task-specific learning and memory. Brain-behavior correlations revealed positive correlations between performance and brain regions in which cytochrome oxidase activity was preserved by methylene blue. These results are the first to demonstrate that methylene blue prevents neurodegeneration and memory impairment by preserving cytochrome oxidase activity and interregional correlation of cytochrome oxidase activity in brain regions susceptible to chronic hypoperfusion. This demonstration provides further support for the hypothesis that lower cerebral blood flow results in an Alzheimer's-like syndrome and that stimulating cytochrome oxidase activity with low-dose methylene blue is neuroprotective.

Citing Articles

Acrobatic training prevents learning impairments and astrocyte remodeling in the hippocampus of rats undergoing chronic cerebral hypoperfusion: sex-specific benefits.

Martini A, Schlemmer L, Lucio Padilha J, Fabres R, Couto Pereira N, Pereira L Front Rehabil Sci. 2024; 5:1375561.

PMID: 38939055 PMC: 11208732. DOI: 10.3389/fresc.2024.1375561.


Histochemical mapping of the duration of action of photobiomodulation on cytochrome c oxidase in the rat brain.

Wade Z, Barrett D, Davis R, Nguyen A, Venkat S, Gonzalez-Lima F Front Neurosci. 2023; 17:1243527.

PMID: 37700747 PMC: 10493319. DOI: 10.3389/fnins.2023.1243527.


Photobiomodulation of Cytochrome c Oxidase by Chronic Transcranial Laser in Young and Aged Brains.

Cardoso F, Barrett D, Wade Z, Gomes da Silva S, Gonzalez-Lima F Front Neurosci. 2022; 16:818005.

PMID: 35368252 PMC: 8971717. DOI: 10.3389/fnins.2022.818005.


Pretreatment with combined low-level laser therapy and methylene blue improves learning and memory in sleep-deprived mice.

Marzabadi E, Meftahi G, Refahi S Lasers Med Sci. 2022; 37(5):2403-2412.

PMID: 35059872 DOI: 10.1007/s10103-021-03497-6.


The Potentials of Methylene Blue as an Anti-Aging Drug.

Xue H, Thaivalappil A, Cao K Cells. 2021; 10(12).

PMID: 34943887 PMC: 8699482. DOI: 10.3390/cells10123379.

References
1.
Plaschke K . Aspects of ageing in chronic cerebral oligaemia. Mechanisms of degeneration and compensation in rat models. J Neural Transm (Vienna). 2005; 112(3):393-413. DOI: 10.1007/s00702-004-0191-2. View

2.
Bruchey A, Gonzalez-Lima F . Behavioral, Physiological and Biochemical Hormetic Responses to the Autoxidizable Dye Methylene Blue. Am J Pharmacol Toxicol. 2011; 3(1):72-79. PMC: 2867617. DOI: 10.3844/ajptsp.2008.72.79. View

3.
Callaway N, Riha P, Wrubel K, McCollum D, Gonzalez-Lima F . Methylene blue restores spatial memory retention impaired by an inhibitor of cytochrome oxidase in rats. Neurosci Lett. 2002; 332(2):83-6. DOI: 10.1016/s0304-3940(02)00827-3. View

4.
Erecinska M, Silver I . ATP and brain function. J Cereb Blood Flow Metab. 1989; 9(1):2-19. DOI: 10.1038/jcbfm.1989.2. View

5.
Shang Y, Cheng J, Qi J, Miao H . Scutellaria flavonoid reduced memory dysfunction and neuronal injury caused by permanent global ischemia in rats. Pharmacol Biochem Behav. 2005; 82(1):67-73. DOI: 10.1016/j.pbb.2005.06.018. View